Physician profile
Michel Samaha
NPI 1346206661
$94,324.53
in general payments reported to CMS, 2019-2025
33 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $9,559 · 2021: $14K · 2022: $6,353 · 2023: $50K · 2024: $1,094 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $48K · Food and Beverage: $3,903 · Travel and Lodging: $280 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $47,775.00 |
| Food and Beverage | $3,902.98 |
| Travel and Lodging | $279.74 |
| Education | $161.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $73,968.48 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Mylan Specialty L.P. | $14,004.19 | 2019-2023 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $2,545.61 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Genzyme Corporation | $776.17 | 2019-2025 | |
| Insmed, INC. | $467.35 | 2019-2025 | Arikayce |
| Mallinckrodt Hospital Products INC. | $411.56 | 2020-2024 | Acthar |
| Regeneron Healthcare Solutions, INC. | $329.76 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $277.86 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.80 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $140.80 | 2022-2025 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $103.90 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $99.00 | 2025 | |
| Advanced Respiratory, INC | $94.12 | 2020 | |
| Grifols USA, LLC | $91.27 | 2019-2025 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $80.61 | 2023-2024 | Sunosi |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $77.27 | 2022 | |
| Mallinckrodt Enterprises LLC | $71.15 | 2019 | |
| Lilly USA, LLC | $68.30 | 2025 | Zepbound |
| Tactile Systems Technology INC | $54.37 | 2025 | Flexitouch Plus, Nimbl |
| Merck Sharp & Dohme LLC | $47.29 | 2024 | Keytruda |
| Covidien LP | $46.43 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $42.85 | 2022-2025 | Opsynvi |
| Baxter Healthcare | $41.56 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $40.00 | 2023 | |
| Amgen INC. | $38.87 | 2022 | |
| Verona Pharma, INC. | $38.39 | 2025 | Ohtuvayre |
| Circassia INC. | $31.44 | 2019-2020 | |
| Electromed, INC. | $23.39 | 2024 | Smartvest |
| Viiv Healthcare Company | $15.89 | 2022 | |
| Gilead Sciences, INC. | $15.06 | 2021 | |
| Genentech USA, INC. | $14.58 | 2019 | |
| United Therapeutics Corporation | $14.42 | 2025 | Tyvaso |
| Pfizer INC. | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michel Samaha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.